CCDI Cartoon Exposes “Prescription Data Rebates” Corruption in China’s Healthcare System
China’s Central Commission for Discipline Inspection (CCDI), the country’s anti-graft bureau, has released a cartoon...
Policy / Regulatory
Shanghai Updates Biomedical R&D Import Pilot for Streamlined Customs Clearance
The Shanghai Municipal Commission of Commerce, in collaboration with Shanghai Customs and the Shanghai Municipal...
NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has released a notification disclosing the drugs that have...
Henan Leads 19-Province Alliance for Volume-Based Drug Procurement Tender
A new inter-provincial alliance, led by Henan, has formed a 19-strong group to conduct a...
NHC Addresses Anti-Corruption Efforts in Pharmaceutical Industry Nationwide
The National Health Commission (NHC) convened a conference to address questions on the ongoing anti-corruption...
China Unveils State Council Measures to Boost Foreign Direct Investment
The State Council of China has demonstrated its commitment to encouraging greater foreign investment by...
Hunan HSA Implements Direct BMI Fund Payments for VBP-Winning Drugs and Consumables
The Hunan Healthcare Security Administration (HSA) bureau has released a notice stating that effective from...
SAMR and Nine Ministries Tighten Regulations on Forums and Conferences in China
The State Administration for Market Regulation (SAMR) of China, in conjunction with nine other ministries,...
Audit Reveals Illicit Payments and Inflated Prices in Pharmaceutical Industry
An audit has shed light on the use of third-party business promotion companies as a...
Shanghai Health Commission Issues Regulations to Curb Unhealthy Pharmaceutical Practices
In alignment with the No. 75 Document by the National Health Commission, the Shanghai...
National Health Commission Unveils 10 Measures to Enhance Primary Healthcare Services
The National Health Commission has issued a Notice outlining “Measures for Grassroots Health and Convenient...
GuangDong Pharmaceutical Association Releases Updated Off-Label Drug List for 2023
The GuangDong Pharmaceutical Association has released the 2023 version of its off-label drug list, marking...
Shanghai’s SMPA Reduces Ceiling Price for Non-Winning Bids in Artificial Joint VBP Tender
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has issued a notification regarding an artificial joint volume-based...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
Shanghai HSA Unveils Measures to Boost Access to Innovative Drugs and Devices
The Healthcare Security Administration (HSA) in Shanghai has recently released a set of Measures aimed...
CDE Releases Draft Guidelines for Clinical Pharmacology Research of Chemical Modified Drugs
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Pharmacological Research...
NMPA Seeks Public Input on Strengthening Supervision of Medical Device Contract Manufacturing
The National Medical Products Administration (NMPA) is currently seeking public feedback on the “Opinions on...
China’s NHC Launches Trial Specifications for Clinical Decision Support Systems in Hospitals
The National Health Commission (NHC) has issued a set of specifications for the application and...
NHSA Issues 2023 Guidelines: Enhancing Basic Medical Insurance and Major Illness Coverage
The National Healthcare Security Administration (NHSA) has released the “Notice on Ensuring Basic Healthcare Security...
CDE Issues Guiding Principles for Natural History Research in Rare Disease Drug Development
The Center for Drug Evaluation (CDE) has released the “Guiding Principles for Natural History Research...